Drug
Evenamide Bid
Evenamide Bid: highest development phase Phase 3, developed by Newron Pharmaceuticals SPA. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Newron Pharmaceuticals SPA
Trials
| Drug | Phase | Indication |
|---|---|---|
| Evenamide 15 mg bid NCT07184619 | Phase 3 | Treatment-resistant Schizophrenia |
Latest
No recent events.
Follow Evenamide Bid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.